Alychlo's Significant Shareholding Notification to Fagron

Author: Evelyn Baker Updated: 07-18-2025 12:15 PM

Understanding Alychlo's Notification to Fagron

Fagron recently received a significant notification regarding major shareholdings, specifically focusing on Alychlo NV. This communication aligns with the Belgian law concerning the disclosure of investor shareholding changes. The announcement underscores the importance of transparency in the operations of publicly listed companies.

Key Details of the Notification

On 14 July, Fagron was informed by Alychlo that they had crossed a notable threshold regarding their shareholding. Alychlo's shareholding fell below 3% due to the disposal of voting securities or voting rights previously held. This specific change took effect following a transaction that took place on 25 July of the preceding year.

The Figures Behind the Announcement

As of 25 July, Alychlo NV possessed a total of 2,139,886 voting rights. Additionally, Marc Coucke, a parent undertaking within the context of the notification, also held a minor share of 7,047 voting rights. When examined against the total amount of voting rights at that time—73,228,904—Alychlo NV and Coucke collectively accounted for 2.93% of the overall voting rights.

Further Insights into Fagron's Operations

Fagron is a prominent player in the pharmaceutical compounding sector, committed to enhancing personalized medicine across a wide array of healthcare environments. Operating in over 30 countries, Fagron places significant emphasis on delivering tailored medication solutions to hospitals, pharmacies, and clinics.

Corporate Structure and Management

The company, headquartered in Nazareth, Belgium, is officially listed on both the Euronext Brussels and Euronext Amsterdam exchanges under the ticker symbol 'FAGR'. The operational activities of Fagron are coordinated by Fagron BV, a Dutch entity based in Rotterdam, which is pivotal in the execution and management of the company’s extensive service offerings.

Communication and Investor Relations

For stakeholders and potential investors, Ignacio Artola serves as Fagron's Global Investor Relations Leader. Those interested in further inquiries can reach out directly through their official communication channels. Fagron is dedicated to maintaining an open dialogue with their investors, ensuring that they are constantly informed about changes and developments that impact their investment decisions.

Commitment to Transparency

Fagron values openness and transparency with its shareholders and the public. The recent notification from Alychlo NV exemplifies the active oversight of shareholding changes that is critical for maintaining trust in the corporate governance landscape. This commitment to transparency helps fortify Fagron’s reputation as a reliable entity in the pharmaceutical industry.

Frequently Asked Questions

What was the nature of the notification received from Alychlo?

The notification indicated that Alychlo NV's shareholding in Fagron crossed below the 3% threshold due to a reduction in their voting rights.

When did the shareholding change occur?

The change in Alychlo's shareholding took effect on 25 July of the previous year, which prompted the notification.

What percentage of voting rights do Alychlo and Marc Coucke hold now?

Together, Alychlo NV and Marc Coucke hold about 2.93% of the total voting rights as of 25 July.

Who can I contact for more information about Fagron?

Ignacio Artola, Fagron's Global Investor Relations Leader, can be contacted for further inquiries regarding the company's operations and investor relations.

Where is Fagron primarily based?

Fagron is based in Nazareth, Belgium, with operational management conducted by Fagron BV in Rotterdam, Netherlands.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.